Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Interest & Investment Income: 2009-2013

Historic Interest & Investment Income for Catalyst Pharmaceuticals (CPRX) over the last 5 years, with Dec 2013 value amounting to $47,421.

  • Catalyst Pharmaceuticals' Interest & Investment Income fell 42.59% to $5,924 in Q3 2014 from the same period last year, while for Sep 2014 it was $76,538, marking a year-over-year increase of 119.55%. This contributed to the annual value of $47,421 for FY2013, which is 216.65% up from last year.
  • Per Catalyst Pharmaceuticals' latest filing, its Interest & Investment Income stood at $47,421 for FY2013, which was up 216.65% from $14,976 recorded in FY2012.
  • Over the past 5 years, Catalyst Pharmaceuticals' Interest & Investment Income peaked at $47,421 during FY2013, and registered a low of $10,985 during FY2011.
  • Over the past 3 years, Catalyst Pharmaceuticals' median Interest & Investment Income value was $14,976 (recorded in 2012), while the average stood at $24,461.
  • In the last 5 years, Catalyst Pharmaceuticals' Interest & Investment Income plummeted by 46.64% in 2010 and then skyrocketed by 216.65% in 2013.
  • Over the past 5 years, Catalyst Pharmaceuticals' Interest & Investment Income (Yearly) stood at $33,466 in 2009, then slumped by 46.64% to $17,858 in 2010, then slumped by 38.49% to $10,985 in 2011, then soared by 36.33% to $14,976 in 2012, then surged by 216.65% to $47,421 in 2013.